|Articles|May 10, 2017

INC Research and inVentiv Health to Merge

INC Research and inVentiv Health announced that their Boards of Directors have unanimously approved a merger agreement.

INC Research and inVentiv Health announced that their Boards of Directors have unanimously approved a merger agreement. This merger would combine both businesses creating the second largest biopharmaceutical outsourcing provider.

Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

Why Patient Input Comes in Too Late—and What Earlier Engagement Changes

ByAmélie Lothe,Andy Studna, Senior Editor

September 14th 2026

ACT Brief: Epilepsy Trial Endpoints, Lab Orchestration and Scientific Intent, and Systems Over Point Solutions

ByAndy Studna, Senior Editor

September 14th 2026

Lab orchestration is often reduced to scheduling and automation, but a connected scientific record across the physical, logical, and digital domains is what actually makes AI-ready research possible. Credit: Stock.Adobe.com/VStudio.

Lab Orchestration Is Not What You Think It Is

ByRyan Bernhardt

September 11th 2026

Why Seizure Counts Alone Can't Define Success in Epilepsy Trials

ByAmélie Lothe,Andy Studna, Senior Editor

September 11th 2026

ACT Brief: Patient Voice in Protocol Design, AI-Informed Recruitment Workflows, and Engagement Maturity Beyond Performative

ByAndy Studna, Senior Editor

September 11th 2026

Trending on Applied Clinical Trials Online

Recruitment in the Age of AI: Q&A with John Worden, Javara

Why Patient Input Comes in Too Late—and What Earlier Engagement Changes

Lab Orchestration Is Not What You Think It Is

What It Actually Means to Embed the Patient Voice in Trial Design

From Participation to Understanding: Reframing Engagement in Clinical Trials